Hematologic Neoplasms: all 1,494 studies
Page 14 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- National Marrow Donor Program Long-Term Donor Follow-UpCompletedNCT01362179
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.CompletedNCT01353625Phase 1
- Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)CompletedNCT01344707Phase 1
- CD56+CD3- NK Cells Following Allogeneic Stem Cell TransplantationWithdrawnNCT01336478Phase 1
- WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular ElectroporationCompletedNCT01334060Phase 2
- Intra-bone Cord Blood TransplantationStatus unknownNCT01332006Phase 2
- A Study Of Panobinostat In Children With Refractory Hematologic MalignanciesCompletedNCT01321346Phase 1
- A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological MalignanciesCompletedNCT01317927Phase 1
- Study of Fludarabine Drug Exposure in Pediatric Bone Marrow TransplantationCompletedNCT01316549
- AMG 319 Lymphoid Malignancy FIHCompletedNCT01300026Phase 1
- Symptom Experience and Self-management After Haematopoietic Stem Cell TransplantationCompletedNCT01275534
- Study of CA-18C3 in Subjects With Advanced Hematologic MalignanciesCompletedNCT01260545Phase 1
- Umbilical Cord Blood Transplant for Children With Lymphoid Hematological MalignanciesWithdrawnNCT01247688Not applicable
- Study of Red Blood Cell Transfusion Triggers in Patients Undergoing Hematopoietic Stem Cell TransplantationCompletedNCT01237639Phase 3
- Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB)WithdrawnNCT01235468Phase 1
- Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK CellsStatus unknownNCT01220544Phase 1/2
- Thymoglobulin in Unrelated Hematopoietic Progenitor Cell TransplantationStatus unknownNCT01217723Phase 3
- Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETHStatus unknownNCT01212796
- Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)SuspendedNCT01211691Phase 1/2
- Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological MalignanciesCompletedNCT01204164Phase 1
- Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantActive, not recruitingNCT01199562
- A Dose-escalation Study in Subjects With Advanced MalignanciesCompletedNCT01195311Phase 1
- Dose Escalation of IPI-493 in Hematologic MalignanciesTerminatedNCT01193491Phase 1
- Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic MalignanciesCompletedNCT01175785Phase 2
- The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"CompletedNCT01172132
- Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological MalignanciesWithdrawnNCT01168882Phase 1
- T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic MalignanciesWithdrawnNCT01163201Phase 1/2
- Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic MalignancyTerminatedNCT01148160
- 4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesCompletedNCT01139151Phase 1
- ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic MalignanciesCompletedNCT01110473Phase 1
- Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT01086735Phase 1/2
- Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell TransplantationCompletedNCT01081405Not applicable
- A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological MalignanciesTerminatedNCT01080664Phase 1
- A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell TransplantCompletedNCT01069887
- Dose-range Finding Treosulfan-based ConditioningCompletedNCT01063647Phase 1/2
- Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised PatientsCompletedNCT01060462
- Anidulafungin in Patients With Hematologic MalignanciesTerminatedNCT01053884Phase 2
- Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given Twice Weekly for Three Consecutive Weeks in Patients With Advanced Hematologic MalignanciesCompletedNCT01034475Phase 1
- Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical DonorCompletedNCT00993486Phase 1/2
- Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological MalignanciesCompletedNCT00990717Phase 1
- Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic MalignancyCompletedNCT00990587Phase 1
- Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes InfusionCompletedNCT00987987Phase 1/2
- Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyTerminatedNCT00963495Phase 1
- Cancer: Thriving and Surviving Online Workshop and Study for Cancer SurvivorsCompletedNCT00962494Phase 2
- Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic MalignanciesTerminatedNCT00943293Phase 1
- Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell TransplantationStatus unknownNCT00934557Phase 3
- Extracorporal Photopheresis Pilot StudyStatus unknownNCT00930566Phase 1/2
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic MalignanciesCompletedNCT00908167Phase 1
- Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological MalignanciesCompletedNCT00904787Phase 1
- Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate CancerCompletedNCT00900614Phase 1
- Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic DisordersCompletedNCT00897260Not applicable
- A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic TransplantationCompletedNCT00894049Phase 2
- Pharmacologic Optimization of VoriconazoleCompletedNCT00893555Phase 3
- Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?CompletedNCT00892502Not applicable
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyCompletedNCT00891137Phase 1
- Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.CompletedNCT00890500Phase 1
- Intrabone Infusion of Cord Blood in Adults With Hematological MalignanciesCompletedNCT00886522Phase 2
- Exercise During Chemotherapy for Patients With Hematological MalignanciesStatus unknownNCT00884364Phase 3
- Repeat Dose Safety Study for Compound to Treat Hematologic CancerCompletedNCT00881946Phase 1/2
- Risk of Hepatitis B Virus Reactivation in Patients Undergoing AllograftingCompletedNCT00876148
- FTS Study in Patients With Advanced Hematologic MalignanciesCompletedNCT00867230Phase 1
- Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic MalignanciesCompletedNCT00845819Phase 2
- Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and BusulfanCompletedNCT00843947Phase 2
- Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological MalignanciesCompletedNCT00841724Phase 2
- A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory MalignanciesCompletedNCT00840190Phase 1
- A Study of BMS-863233 in Patients With Hematologic CancerTerminatedNCT00838890Phase 1/2
- Intrabone Cord Blood TransplantationStatus unknownNCT00838019Phase 4
- Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic MalignanciesCompletedNCT00825487Phase 1
- Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic MalignanciesCompletedNCT00824135Phase 1
- Open-Label Study to Assess the Safety/Tolerability in Patients With Solid TumorsCompletedNCT00820560Phase 1
- A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesCompletedNCT00807677Phase 1
- Safety Study of ABT-263 in Combination With Rituximab in Lymphoid CancersCompletedNCT00788684Phase 1
- Infusional C-myb ASODN in Advanced Hematologic MalignanciesCompletedNCT00780052Phase 1
- Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem CellsCompletedNCT00770523
- Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT00750126Phase 2
- A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)CompletedNCT00749502Phase 1
- A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With AzacitidineCompletedNCT00741234Phase 1
- In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T CellsWithdrawnNCT00731705
- Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple MyelomaCompletedNCT00722488Phase 1
- AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or PrednisoneCompletedNCT00719147
- Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic MalignanciesCompletedNCT00718757Phase 1
- Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic MalignanciesCompletedNCT00710528Phase 1
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic MalignanciesCompletedNCT00697671Phase 1
- Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked ProductsCompletedNCT00695279
- Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)CompletedNCT00693927Phase 2
- Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or MyelodysplasiaCompletedNCT00677859Phase 1
- Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic MalignanciesCompletedNCT00675831Phase 1
- Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic MalignanciesWithdrawnNCT00666081Phase 1
- Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological MalignanciesCompletedNCT00660920Phase 1
- Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic MalignanciesCompletedNCT00642031Phase 1
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid TumorsCompletedNCT00640796Phase 1
- A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.CompletedNCT00623870Phase 1
- Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related DonorsCompletedNCT00618969Phase 2
- A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant DisordersStatus unknownNCT00596999
- Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological MalignanciesCompletedNCT00595686Phase 1
- A Phase I Trial of ZIO-101 in Hematologic CancersCompletedNCT00592046Phase 1
- Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological MalignanciesStatus unknownNCT00580450Phase 1/2
- UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological MalignanciesWithdrawnNCT00578045Phase 1
- A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in ChinaCompletedNCT00559065
- A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological MalignancyCompletedNCT00558675Phase 1/2